VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10017950 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10059146 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10059148 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10059150 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10059149 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10059147 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
TVIS10060220 | HBV | ENSG00000229314.6 | protein_coding | ORM1 | No | No | 5004 | P02763 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | ORM1 |
---|---|
DrugBank ID | DB00276 |
Drug Name | Amsacrine |
Target ID | BE0000925 |
UniProt ID | P02763 |
Regulation Type | |
PubMed IDs | 10803926 |
Citations | Finlay GJ, Baguley BC: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol. 2000;45(5):417-22. |
Groups | Approved; Investigational |
Direct Classification | Acridines |
SMILES | COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1 |
Pathways | |
PharmGKB | PA10309 |
ChEMBL | CHEMBL43 |